Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Ruben A Mesa
Relevance of Weight Loss, Splenomegaly, and Hypocholesterolemia in the Treatment of Myeloproliferative Neoplasms— Implications for a JAK2 Inhibitor Era
Oncology & Hematology Review (US)
Related publications
An Exciting New Era in the Treatment of Myeloproliferative Neoplasms
Oncology & Hematology Review (US)
JAK2 and MPL Mutations in Myeloproliferative Neoplasms: Discovery and Science
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
JAK2 Haplotype Is a Major Risk Factor for the Development of Myeloproliferative Neoplasms
Nature Genetics
Genetics
JAK2 Exon 14 Deletion in Patients With Chronic Myeloproliferative Neoplasms
PLoS ONE
Multidisciplinary
The Role of the JAK2 GGCC Haplotype and the TET2 Gene in Familial Myeloproliferative Neoplasms
Haematologica
Hematology
JAK2, CALR, and MPL Mutation Spectrum in Japanese Patients With Myeloproliferative Neoplasms
Haematologica
Hematology
Characterization of CD34+ Hematopoietic Progenitor Cells in JAK2 V617F and CALR -Mutated Myeloproliferative Neoplasms
Leukemia Research
Cancer Research
Oncology
Hematology
Classification of Myeloproliferative Disorders in the JAK2 Era: Is There a Role for Red Cell Mass?
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
Role of Mesenchymal Stromal Cells and Their Extracellular Vesicles microRNAs in JAK2 Myeloproliferative Neoplasms
